Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBerberine and Wegovy are sometimes taken together, but there is no clinical trial evidence that the combination is safe or more effective than semaglutide alone. Berberine is an unregulated supplement, not a licensed medicine, and Wegovy is a prescription-only injection that a clinician must assess before prescribing. If you are already on Wegovy and considering adding berberine, or the other way around, the right step is a conversation with your prescriber before you start. Here is what the current evidence actually shows, and why this particular combination deserves careful thought.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide, the active ingredient in Wegovy, works by activating GLP-1 receptors in the gut and brain. It slows stomach emptying, reduces appetite and lowers post-meal blood-sugar spikes. It is a once-weekly injection, titrated from a low starting dose by your prescriber. The NHS medicines page for semaglutide sets out its mechanism and side effects clearly.
Berberine is a compound extracted from plants including barberry and goldenseal. Some small studies suggest it activates AMPK, a cellular energy-sensing pathway, which may modestly lower fasting glucose and improve insulin sensitivity. That mechanism sounds complementary to Wegovy's. The problem is that "complementary" and "safe in combination" are not the same thing. Small glucose-lowering effects can add up, and the supplement market is not subject to the manufacturing standards that licensed medicines must meet. A batch you buy this month may be twice the stated dose; next month's from a different supplier may be half. If you want a detailed look at how these two interact, our page on berberine and Wegovy covers the evidence and the key questions to bring to your prescriber.
Check the label of any berberine product for a GMP (Good Manufacturing Practice) mark. That takes about thirty seconds and is the minimum quality signal worth looking for, though it does not replace a clinical conversation.
The main concern when combining berberine and semaglutide together is additive blood-glucose lowering. Neither drug is classified as a hypoglycaemic agent in isolation for people without diabetes, but combined effects on insulin sensitivity and gastric emptying could push glucose lower than expected, particularly in people who are restricting calories. Symptoms of low blood sugar, including dizziness, shakiness and confusion, can be subtle and are sometimes mistaken for Wegovy's own side effects.
Wegovy's GI profile (nausea, loose stools, stomach discomfort) is already well documented. Berberine independently causes GI side effects in a meaningful proportion of users. Layering the two raises the likelihood of gut-related symptoms. For some people that means abandoning semaglutide treatment prematurely, which is the worst of all outcomes.
There is also a pharmacokinetic consideration. Wegovy slows gastric emptying. Some research suggests this can alter the absorption of oral supplements and medicines taken at the same time. Whether this affects berberine meaningfully has not been studied directly; you can find broader context on how semaglutide affects the body on our overview page.
At nume, every repeat order goes through a clinical re-review by a GPhC-registered prescriber. If you list berberine on your health questionnaire, that information informs the review. Skipping it does not make the risk disappear; it just means your prescriber cannot account for it. The same applies if you are considering berberine while on Wegovy and wondering whether they interact, or if you have been taking berberine for a while and are now asking whether it is safe to continue alongside your prescription.
Prescribers will typically weigh up your glucose readings, your GI symptom pattern and your broader medication list. That context shapes the answer in a way that a general article cannot. If you want to explore what a prescription weight-loss programme looks like without the uncertainty of unregulated supplements layered on top, you can read about medically supervised weight loss more broadly.
Berberine is cheap. Wegovy is not. People often reach for berberine because it costs a few pounds a month and is easy to buy. Before adding it to an already effective treatment, it is worth asking what you are hoping it will do that Wegovy alone is not doing. If the answer is "speed things up", the evidence simply does not support that expectation for this particular combination. A more productive conversation is with your prescriber about whether your current dose is optimised or whether your diet and activity patterns alongside treatment are where they could be.
For a clear-eyed view of what Wegovy costs through a regulated UK pharmacy and what that price includes, the Wegovy cost page covers that without spin. And if you have specific questions about the practical side of taking berberine with Wegovy, that page goes into further detail. The NHS medicines guidance on semaglutide interactions and precautions is also worth reading before you make a decision either way.
If you are not yet on Wegovy and are weighing up your options, a free consultation with our prescribers is the right place to start rather than combining supplements in the hope of the same effect.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.